Lichen planus (LP) is a mucocutaneous disease of chronic inflammatory nature, commonly seen in dermatological and dental clinics; it is a relatively common disorder of stratified squamous epithelia, frequently exclusively involving the oral cavity. Oral Lichen Planus (OLP) is often asymptomatic, the atrophic-erosive form can cause symptoms ranging from burning sensation to severe pain, interfering with speaking, eating, and swallowing. Lichen planus is regarded as a premalignant lesion. This review discusses the role of hepatitis C virus (HCV), bacterial and fungal infection in LP. Analysing the seroprevalence of HCV infection in LP patients and patients with oral OLP in particular, which was the case in the vast majority of studies, the association varied from 0% to 62% and seemed to be connected to the high HCV seroprevalence in the general population. Candida albicans is present in about 37% of oral LP lesions. The aim of this review is to summarize what is new in the pathogenesis and treatment of OLP

Oral lichen planus. novel acquisitions in the pathogenesis and treatment / R., Saraceno; B., Lorè; A., Ventura; Nistico', S; C., Perugia; S., Chimenti; L., Bianchi. - In: EUROPEAN JOURNAL OF INFLAMMATION. - ISSN 1721-727X. - 11:3(2013), pp. 609-616. [10.1177/1721727X1301100304]

Oral lichen planus. novel acquisitions in the pathogenesis and treatment

Nistico' S
;
2013

Abstract

Lichen planus (LP) is a mucocutaneous disease of chronic inflammatory nature, commonly seen in dermatological and dental clinics; it is a relatively common disorder of stratified squamous epithelia, frequently exclusively involving the oral cavity. Oral Lichen Planus (OLP) is often asymptomatic, the atrophic-erosive form can cause symptoms ranging from burning sensation to severe pain, interfering with speaking, eating, and swallowing. Lichen planus is regarded as a premalignant lesion. This review discusses the role of hepatitis C virus (HCV), bacterial and fungal infection in LP. Analysing the seroprevalence of HCV infection in LP patients and patients with oral OLP in particular, which was the case in the vast majority of studies, the association varied from 0% to 62% and seemed to be connected to the high HCV seroprevalence in the general population. Candida albicans is present in about 37% of oral LP lesions. The aim of this review is to summarize what is new in the pathogenesis and treatment of OLP
2013
oral lichen planus; HCV; mucocutaneous disorders; quamous cell carcinoma; cyclosporine; tacrolimus
01 Pubblicazione su rivista::01a Articolo in rivista
Oral lichen planus. novel acquisitions in the pathogenesis and treatment / R., Saraceno; B., Lorè; A., Ventura; Nistico', S; C., Perugia; S., Chimenti; L., Bianchi. - In: EUROPEAN JOURNAL OF INFLAMMATION. - ISSN 1721-727X. - 11:3(2013), pp. 609-616. [10.1177/1721727X1301100304]
File allegati a questo prodotto
File Dimensione Formato  
Saraceno_Oral_2013.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 285.16 kB
Formato Adobe PDF
285.16 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1687168
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact